Susan Orr
Directeur/Bestuurslid bij OPTHEA LIMITED
Vermogen: - $ op 30-04-2024
Profiel
Susan Orr is a professional with current positions as Non-Executive Director at Opthea Ltd., Director at Retina Global, and Chief Medical Officer at Claris Biotherapeutics, Inc. She previously worked as Chief Executive Officer at Notal Vision Ltd.
from 2016 to 2019.
Orr received her undergraduate and doctorate degrees from The University of Waterloo.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OPTHEA LIMITED
-.--% | 28-09-2023 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Susan Orr
| Bedrijven | Functie | Begin |
|---|---|---|
| OPTHEA LIMITED | Directeur/Bestuurslid | 21-04-2022 |
Claris Biotherapeutics, Inc.
 Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Operationeel Directeur | - |
| Retina Global | Directeur/Bestuurslid | - |
Eerdere bekende functies van Susan Orr
| Bedrijven | Functie | Einde |
|---|---|---|
Notal Vision Ltd.
 Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Algemeen Directeur | 23-10-2019 |
Opleiding van Susan Orr
| The University of Waterloo | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Health Services |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Health Technology |
| Retina Global |
